Objective: To develop a combined barrier method and drug delivery system ("hybrid system") for preventing postoperative peritoneal adhesions, which could combine the biocompatibility and ease of application of in situ cross-linkable hydrogels with the controlled release features of polymeric nanoparticles. Methods: Poly(lactic-co-glycolic acid) nanoparticles were dispersed in aldehyde-and hydrazide-modified hyaluronic acids (HA), then combined via a double-barreled syringe. The material was subjected to mechanical testing and was assayed for in vitro cytotoxicity to murine mesothelial cells. Subsequently, it was tested for biocompatibility by intraperitoneal injection in mice. The hybrid's effectiveness in preventing postsurgical adhesions was assessed using a rabbit sidewall defect-cecum abrasion model, where it was applied to both injured surfaces. Results: The in situ hybrid gel system formed a flexible and durable hydrogel in less than 10 seconds. It had low in vitro cytotoxicity. In the mouse, the cross-linked HA maintained the polymeric nanoparticles in the peritoneum for 1 week, which we had previously shown would have cleared in less than 2 days, and no animals developed adhesions. Notably, the hybrid gel, even in the absence of encapsulated drug, was highly effective in preventing peritoneal adhesions in the rabbit model employed. Animals treated with the hybrid (n ϭ 8) had no adhesions in 62.5% of cases, and none had adhesions that could only be separated by sharp dissection. In contrast, only 4.2% of untreated animals (n ϭ 24) had no adhesions, and 58.3% developed adhesions requiring sharp dissection. Conclusions: The hybrid cross-linked HA-nanoparticle system described here appears to be a biocompatible and highly effective adhesion barrier, which could also deliver antiadhesion drugs. FIGURE 1. SEM pictures of (A) PLGA nanoparticles, (B) lyophilized hybrid gel, and (C) lyophilized HAX gel. Note the roughness of hybrid gel surface (B inset). Scale bar ϭ (A) 100 nm (B) 10 m, and (C) 10 m.
A dhesions are a major cause of postsurgical morbidity and mortality and entail a substantial medical economic burden. Consequently, methods for preventing such adhesions have been the focus of extensive research. An approach to preventing peritoneal adhesions is to apply physical barriers, which can separate the injured regions during peritoneal healing. 1 A few barrier devices based on polysaccharides are in commercial use. However, issues of efficacy and practicality aside, these devices do not address the pathogenesis of adhesions. A large number of drug therapies have also been tested, using drugs with a broad range of mechanisms of action. 2, 3 Many have shown promise in animal studies, but few have penetrated into clinical practice. One limitation of conventional intraperitoneal drug therapy may be that drugs are rapidly cleared. The hypothesis underlying our research is that the application of controlled release technology could improve the efficacy of drugs by maintaining their local concentrations.
Polymeric microparticulate and nanoparticulate systems have a long history of use for drug delivery. One of the most commonly used biodegradable polymer families, that of poly(lactic-coglycolic acid) (PLGA), is approved for use in humans, biodegradable and known to be biocompatible at many sites. However, we have found that intraperitoneally applied microparticles (5-250 m) composed of PLGA (90 kDa) cause a high rate of peritoneal adhesions in mice. 4 In contrast, PLGA nanoparticles (ϳ265 nm) of the same polymer caused few adhesions, but this was due to their rapid clearance from the peritoneum. 4 This observation suggests that the nanoparticles may not be suitable for sustained drug release within the peritoneum unless they are protected from the rapid clearance.
Here we describe a composite hydrogel system for intraperitoneal drug delivery that is a hybrid between a hydrogel-based barrier device and a polymeric drug delivery system. PLGA nanoparticles are entrapped within an in situ cross-linkable hyaluronic acid hydrogel. One hypothesis is that the hydrogel will retain the nanoparticles within the peritoneum while acting as a conventional barrier device but will also prevent the retained polymer from causing adhesions. We examine physical characteristics of the composite hydrogel, its in vitro cytotoxicity, and in vivo biocompatibility and anti-adhesion efficacy.
METHODS

Materials
Hyaluronic acids (HA, nominal weights 1.36 MDa and 490 kDa) were purchased from Genzyme Corporation (Cambridge, MA). PLGA (lactide:glycolide ϭ 65:35; molecular weight, 90,000) was obtained from Alkermes (Cambridge, MA). Polyvinyl alcohol (PVA, molecular weight, 6000) was purchased from Polysciences, Inc. (Warrington, PA). All other reagents were purchased from Sigma-Aldrich (St. Louis, MO) unless specified otherwise.
Preparation of PLGA Nanoparticles
PLGA 200 mg was dissolved in 5 mL of a 3:2 mixture of methylene chloride and dimethylsulfoxide. The polymer solution was directly added to 20 mL of 5% PVA. The mixture was then homogenized for 1 minute using a sonicator (Vibracell VC-250, Sonics & Materials Inc., Dunbury, CT) to generate an oil-water emulsion. The formed emulsion was added to 100-mL distilled water and stirred overnight at room temperature. The remaining solvents were removed under reduced pressure. The nanoparticles were collected by centrifugation at 25,000 rpm for 20 minutes using an L8-70M ultracentrifuge (Beckman, Fullerton, CA) and an SW 28 swinging bucket rotor, and further purified by passing through an ultrafiltration membrane (Ultracel Amicon YM100, Millipore, Billerica, MA) prior to lyophilization. Particle size and charge were measured with a ZetaPALS zeta potential analyzer (Brookhaven Instruments Corporation, Holtsville, NY).
Preparation of Modified Hyaluronic Acids and Cross-linked Hydrogels
Cross-linkable HA derivatives were synthesized as described. 5, 6 Cross-linked hyaluronic acid hydrogels without nanoparticles (HAX) were prepared by mixing 20 mg/mL solutions of gel precursors (HA-ADH and HA-CHO) with a double-barreled syringe. Composite HAX gels containing PLGA nanoparticles ("hybrid") were prepared by mixing 20 mg/mL solutions of gel precursors in which 20 mg/mL of PLGA nanoparticle were suspended.
Scanning Electron Microscopy
The surface morphology of PLGA nanoparticles and the internal structure of lyophilized hydrogels were examined by scanning electron microscopy. The hydrogels were made by mixing equal volumes of precursor solutions prepared in distilled water. The hydrogels were then lyophilized and fractured after cooling in liquid nitrogen. Samples were sputter-coated with palladium and gold (100 Å thick) and observed using a scanning electron microscope (JEOL JSM 6320, JEOL USA, Inc., Peabody, MA).
Gelation Time
A total of 100 L of HA-ADH in saline containing PLGA nanoparticles (HA-ADH and nanoparticles were both either 10 mg/mL or 20 mg/mL) was placed into a 8 ϫ 35 mm glass vial, under continuous stirring at 155 rpm (Teflon fluorocarbon resin, 5 ϫ 2 mm, Fisher Scientific); 100 L of HA-CHO in saline containing PLGA nanoparticles (same concentrations as for HA-ADH) was then added to the vial. The mixture was stirred until it formed a solid globule, which completely separated from the bottom of the dish; this was considered the gelation time. HAX gels without nanoparticles were also tested. The results are reported as averages and standard deviations of 4 independent measurements.
Rheological Testing
Cylindrical HAX and hybrid gels were prepared by adding 20 mg/mL gel precursor solutions into a rubber mold sandwiched between 2 glass slides. The diameter and thickness of the hydrogels were 8 mm and 3.5 mm, respectively. Rheological measurements were made with an AR1000N rheometer (TA Instruments, New Castle, DE). All experiments used a parallel 8-mm diameter plate at room temperature. Stress modulus, G, was measured by the creep test and the stress sweep test. For the creep test, the hydrogels were subjected to a constant shear stress (5, 10, 20, or 40 Pa) for 90 seconds and then allowed to recover for 90 seconds. After ϳ60 seconds in each creep and recovery step, the strain reached a constant value. G was determined as a reciprocal of the slope of the strain (read at the end of the recovery step) versus stress curve. For the stress sweep test, oscillatory stress was applied in the range 1 to 100 Pa at a constant frequency (0.1 Hz). Elastic modulus, GЈ, obtained at 40 Pa was used as an approximation of G because the viscous modulus, GЈЈ, was close to 0. The results are reported as the averages and standard deviations of 4 independent measurements.
Cell Viability Assay
Human mesothelial cells (ATCC, CRL-9444) were cultured in Medium 199, containing Earle's salts, L-glutamine, and 2.2 g/L sodium bicarbonate and supplemented with 3.3 nmol/L epidermal growth factor, 400 nmol/L hydrocortisone, 870 nmol/L insulin, 20 mmol/L HEPES, and 10% fetal bovine serum (Invitrogen). Cells were seeded into 24-well plates at a density of 50,000 cells per well in 1 mL of culture media. After overnight incubation, 100 L-volume cylindrical hybrid gels (diameter, 5 mm; height, 5.1 mm) or an equal volume of saline were added to each well. Cell viability was assessed with an MTT assay kit (Promega CellTiter 96 Non-Radioactive Cell Proliferation Assay) at 1 and 3 days of incubation. The measured absorbance was normalized to the absorbance of nontreated control cells.
In Vivo Application of Hybrid Gel
Animals were cared for in compliance with protocols approved by the Massachusetts Institute of Technology Committee on Animal Care, in conformity with the NIH guidelines for the care and use of laboratory animals (NIH Publication No. 85-23, revised 1985).
Mouse Intraperitoneal Injection Model
Male SV129 mice (Charles River Laboratories, Wilmington, MA) weighing 20 to 35 g were used as described. 4 Prior to application, materials were sterilized by germicidal UV illumination for 2 hours and dissolved in sterile saline. HA-ADH with PLGA nanoparticles 0.5 mL (10 mg/mL HA-ADH and 20 mg/mL nanoparticles) and HA-CHO 0.5 mL (10 mg/mL HA-CHO containing 20 mg/mL nanoparticles) were placed in sep- arate sterile 1-mL syringes, which were connected to a Baxter dual valve applicator, and coextruded through a 20-gauge needle; 1 mL of sterile hybrid gel was injected into the peritoneum via a single puncture in the left lower quadrant. Animals were killed with carbon dioxide 2 or 7 days after injection, then underwent necropsy to determine whether adhesions or gel residue were present. The spleen size was also noted.
Rabbit Sidewall Defect-Cecum Abrasion Model
Female albino rabbits (Oryctolagus cuniculus; New Zealand White, Covance, Hazleton, PA) (3 Ϯ 0.5 kg) were used as model animals. Anesthesia was induced using ketamine (35 mg/kg i.m.) and xylazine (5 mg/kg i.m.); maintenance was achieved using 1% to 3% isoflurane in balance oxygen administered via endotracheal tube. Aseptic technique was used throughout. To induce adhesions, a 10-cmlong midline incision was made along the linea alba and through the peritoneum. Subsequently, a 3 ϫ 4 cm defect comprising the parietal peritoneum and a layer of muscle ϳ1 mm thick was made on the right lateral abdominal wall starting 1 cm away from the midline incision. The antimesenteric side of the cecum was abraded bidirectionally for 80 to 170 times from the 6th haustra distal to the ileocecal junction to the 12th haustra using a sterile surgical brush, resulting in a bleeding surface.
Thirty-two rabbits were assigned randomly to receive no treatment (n ϭ 24) or 10 mL of sterile hybrid gels applied to the sites of injury on the abdominal wall and cecal surface (n ϭ 8) produced as follows. Five mL of HA-ADH with PLGA nanoparticles (20 mg/mL HA-ADH and 20 mg/mL nanoparticles) and 5 mL of HA-CHO (20 mg/mL HA-CHO and 20 mg/mL nanoparticles) were placed in separate sterile 10-mL syringes, which were connected to a Baxter dual valve applicator, and coextruded through a 15-gauge needle. The gel precursors started to gel instantly, conforming to the shape of the applied area. To visual examination, gelation was complete in less than 3 minutes: the hydrogel did not flow beyond that point.
One week after the procedure, animals were killed with intravenous sodium pentobarbital. Adhesions were scored following a modification of a reported method 7 : score 0, no adhesion; score 1, tissues separable by gravity; score 2, tissues separable by blunt dissection; score 3, adhesion re-quiring sharp dissection. The investigator performing the necropsy and scoring the adhesions was not aware of which experimental group to which individual animals belonged.
Histologic Examination
Tissues recovered from the necropsy were fixed in 10% formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin using standard techniques.
Statistical Analysis
Rheological measurements were reported as means and standard deviations, and compared using the Student t test. Cell culture data were expressed as medians with 25th and 75th percentiles since they did not always follow a normal distribution; scores were also reported this way. For these, statistical inferences were made using Mann-Whitney Utests, Kruskal-Wallis tests, or Fisher exact test, using SPSS software (Chicago, IL). A P value Ͻ0.05 on a 2-tailed test was considered statistically significant.
RESULTS
Characterization of Hybrid Gels
The average diameter and zeta potential of PLGA nanoparticles were 278.4 Ϯ 18.7 nm and Ϫ18.1 Ϯ 4.0 mV, respectively. To scanning electron microscopy, the particle size distribution was relatively broad ranging from 50 nm to 300 nm (Fig. 1A) . Lyophilized hybrid gel matrices had continuous pores with a diameter ranging from 5 to 10 m (Fig. 1B) that were comparable to those of HAX gels (Fig.  1C ). The hybrid gels had rough surfaces (Fig. 1B, inset) indicating nanoparticles embedded in gel matrix.
One of the potential advantages of HAX gels as an adhesion barrier is that they can cross-link in situ within a useful time frame. To assess whether incorporation of polymeric nanoparticles interfered with gelation, we compared the gelation times of HAX and hybrid gels. Both systems gelled rapidly upon mixing, without statistically or practically significant difference between the two (Table 1) . Similarly, we wished to ascertain whether nanoparticles affected the mechanical properties of the gels. The stress modulus was unaffected by nanoparticles (Table 1 ).
In Vitro Cell Viability Assay
The effect of hybrid gels on in vitro mesothelial cell viability was assessed with the MTT assay. Cells were grown in the presence of cylindrical 100 L hybrid gels (20 mg/mL HAX ϩ 20 mg/mL PLGA nanoparticles) for up to 3 days. This was done in medium with or without 10 units/mL hyaluronidase, an enzyme that degrades HAX. (In the controls, which provided the denominator for normalizing viability, 100 L of normal saline was added instead of the gel.) Cell viability was well maintained at 1 and 3 days of incubation, irrespective of the presence of hyaluronidase. There were no statistically significant differences between the groups shown in Figure 2 .
Biocompatibility in the Mouse Intraperitoneal Injection Model
One hypothesis underlying this work was that the HAX would keep nanoparticles within the peritoneum and at the same time prevent the formation of adhesions from the presence of high molecular-weight PLGA. To test this, we injected 1 mL of 10 or 20 mg/mL HAX containing 20 mg of PLGA nanoparticles to the mouse peritoneum. Animals injected with nanoparticles in the absence of HAX had previously been shown to leave the peritoneum within 2 days, leaving little polymeric residue, and to frequently have en-larged and discolored spleens with foamy macrophages. 4 In contrast, on necropsy 2 days after injection (Table 2) , the hybrid gels containing HAX 10 mg/mL remained at the injection site as discrete masses that were easily separated from the surrounding abdominal contents (Fig. 3A) . The hybrid gels containing HAX 20 mg/mL seemed more adherent to the abdominal contents but were still easily separable from the surface of the viscera, although they did leave some residue (Fig. 3B) . No adhesions or abnormalities in spleen size or color were noted in either group. A further hybrid group containing 20 mg/mL HAX was euthanized 7 days after injection. Gels were seen in 3 of 4 mice (Fig. 3C) , whose masses were comparable to those recovered after 2 days. In the one mouse with no residual gel, the spleen was morphologically and histologically similar to the others in the group (ie, normal); we cannot exclude the possibility that the gel was initially injected either outside the peritoneum or within the lumen of the bowel. Increased vascularity was noted at the periphery of many gels, as can be seen in all panels of Figure 3 .
Effectiveness of Hybrid Gels in an Abdominal Sidewall Defect-Cecum Abrasion Model in the Rabbit
Eight rabbits received laparotomies in which the cecum was abraded and a segment of the adjacent abdominal wall was excised, as described in Methods. The hybrid gel (20 mg of nanoparticles in 10 mL of 20 mg/mL HAX) was painted on the injured sites. At the time of necropsy 1 week later (Table 3) , their weight loss was comparable to that in a control group (same injury, no treatment, n ϭ 24) (P Ͼ 0.5, two-tail t test). The median adhesion score was dramatically lower in the group treated with the hybrid gel (P Ͻ 0.001, Mann-Whitney U test; Ͼ0.001, Fisher exact test). While 58.3% of animals in the control group developed score 3 adhesions (firm links that could only be separated by cutting), none in the treated group developed score 3 adhesions (P ϭ 0.013, Mann-Whitney U test; P ϭ 0.004, Fisher exact test). Five of 8 animals (62.5%) in the treated group showed no tissue adherence at all (Fig. 4B) , compared with 1 of 24 (4.2%) in the control group (0.013, Mann-Whitney U test; P ϭ 0.002, Fisher exact test). Of the 3 animals in the hybrid gel-treated group that developed score 2 adhesions, one was between the cecal surface and the excised abdominal wall near the suture site, one between abraded cecum and nonabraded cecum, and one developed two score 2 adhesions: between abraded cecum and nonabraded cecum, and between the cecal surface and the injured abdominal wall near the suture site. Therefore, many of the sites where these score 2 adhesions occurred were sites that were not covered with the hybrid gel.
On necropsy, the hybrid gels were noted to still be at the sites where they were applied, but the quantity and mechanical properties appeared to be significantly reduced.
Histology
Foamy macrophages, presumed to contain polymeric debris, were noted in stained slides of gel residue recovered from the rabbit peritoneum ( Fig. 5A, B) ; free polymer (bright spots) was also noted. Foamy macrophages were not found in liver or spleen (not shown). They were also found on the surface of adhesion-free injured abdominal wall (Fig. 5C, D) , where hybrid gel had been applied. Similar foamy macrophages were also noted in gels recovered from mouse peritoneum (Fig. 5B, inset) .
DISCUSSION
The principal purpose of this investigation was to determine the suitability for peritoneal use of a hybrid drug delivery system consisting of polymeric nanoparticles sus- pended within a hyaluronic acid-based cross-linked hydrogel. Specifically, we were interested in its potential applicability in preventing peritoneal adhesions. The principal design considerations were discussed in brief in the introduction. We chose the HAX gel as an encapsulating hydrogel because previously we found that the HAX gel remained in the peritoneum for at least 1 week and showed excellent biocompatibility and prevented adhesions in the rabbit model. Polymeric nanoparticles could be used to enhance the controlled release properties of hydrogels; one advantage over larger microparticles is that they are less likely to cause adhesions if they become separated from the hydrogel, as they will be cleared from the peritoneum. 4 Our data show that incorporation of nanoparticles does not adversely affect in situ cross-linkability and mechanical properties of the HAX gel. The hybrid system (HAX gel containing nanoparticles) has low cytotoxicity in vitro to peritoneal mesothelial cells, is biocompatible in the peritoneum in vivo, and is intrinsically capable of preventing adhesions. The HAX gel successfully maintained the nanoparticles within the peritoneum for the duration of the experiment, as seen by the presence of foamy macrophages in the gel remnants and the lack of such cells in liver and spleen, where they had been noted in mice injected with comparable masses of nanoparticles without HAX. 4 HAX also prevented the formation of adhesions from the retained polymer.
The hybrid gels were highly efficacious in preventing peritoneal adhesions in a rabbit sidewall defect-cecum abrasion model. This was particularly clear when comparing the prevalence of score 3 adhesions, which were firm links that could only be separated by sharp dissection. There were no score 3 adhesions in animals treated with the hybrid gel, in contrast to an incidence of 58.3% in untreated animals. The three cases of score-2 tissue adherence (separable by blunt dissection) occurred either near the suture site or between two cecal surfaces (one of which was not abraded), ie, all adhesions involved areas that were not covered by the hybrid gel. Here, the gel was applied within the confines of the sites of injury. It may be that application of the system across a larger surface area will further increase effectiveness.
This gel system, which forms in situ, is easy to use with a double-barreled syringe or similar device. The relatively rapid gelation time allows the user to apply gel to specific locales without spillage into adjacent regions. (Gelation time can be modified by changing polymer concentration.) This system could therefore be easily applied by a laparoscope or even by percutaneous injection. Potential uses are not restricted to the peritoneum, although biocompatibility has not yet been demonstrated in other locales.
